Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Chemistry & Biodiversity|June 3, 2025
Targeting Cancer Cells With Triazene-Appended Morpholine Chalcones: Antiproliferative Activity and ROS-Dependent Apoptotic MechanismsAhammed Ameen Thottasseri, Sathyapriya Chandramohan, Rajesh Ravichandran, et al.
RSC Advances|June 29, 2022
Uracil derivatives as HIV-1 capsid protein inhibitors: design, in silico, in vitro and cytotoxicity studiesDeepthi Ramesh, Amaresh Kumar Mohanty, Anirban De, et al.
Angewandte Chemie (International Ed. in English)|June 26, 2020
Stimuli-Responsive Cycloaurated "OFF-ON" Switchable Anion TransportersMohamed Fares, Xin Wu, Deepthi Ramesh, et al.
Chemical Biology & Drug Design|March 12, 2025
Targeting Blood-Stage Malaria: Design, Synthesis, Characterization, In Vitro, and In Silico Evaluation of Pyrrolidinodiazenyl ChalconesAhammed Ameen Thottasseri, Vinoth Rajendran, Deepthi Ramesh, et al.
Journal of Materials Chemistry. B|May 4, 2022
Chitosan with pendant (E)-5-((4-acetylphenyl)diazenyl)-6-aminouracil groups as synergetic antimicrobial agentsBalaji Gowrivel Vijayakumar, Deepthi Ramesh, K Santhosh Manikandan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2025
Specific targeting of the pseudogene RPSAP52 reduces ovarian tumor growth in patient-derived orthoxenograft modelsDeepthi Ramesh-Kumar, Anaís Sánchez-Castillo, Marta Soler, et al.
Molecular Therapy. Nucleic Acids|January 17, 2022
Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndromeEdilene Siqueira, Aida Obiols-Guardia, Olga C Jorge-Torres, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored ImmunotherapyRishita Chatterjee, Arturo Simoni-Nieves, An Truong, et al.
Pageof 3